The drug development market is continuing to evolve significantly, creating additional layers of complexity and risk within the clinical supply chain. One of the key challenges sponsors face today is the disconnect that exists between the physical and digital clinical supply chains.

To remove this challenge from the clinical supply equation and support sponsors to fully align and optimise their clinical supply chain, Almac has harnessed over three decades of experience supplying IRT and Clinical Supplies services to develop Almac One™: One Unified Clinical Trial Supply Solution.

Download our latest case study to discover the six reasons you should consider unifying your clinical supply chain with Almac ONE^TM.